Author:
Reed Brian,Butelman Eduardo R.,Yuferov Vadim,Randesi Matthew,Kreek Mary Jeanne
Publisher
Springer Science and Business Media LLC
Subject
Psychiatry and Mental health
Reference86 articles.
1. Paulozzi LJ, Jones CM, Mack KA, Rudd RA. Vital signs: Overdoses of prescription opioid pain relievers – united states, 1999–2008. MMWR Morb Mortal Wkly Rep. 2011;60(3):1487–92.
2. Bond C, LaForge KS, Tian M, Melia D, Zhang S, Borg L, et al. Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: Possible implications for opiate addiction. Proc Natl Acad Sci U S A. 1998;95(16):9608–13.
3. Levran O, Peles E, Randesi M, Shu X, Ott J, Shen PH, et al. Association of genetic variation in pharmacodynamic factors with methadone dose required for effective treatment of opioid addiction. Pharmacogenomics. 2013;14(7):755–68. doi: 10.2217/pgs.13.58 . This study confirmed a prior finding of association of SNPs in CYP2B6 with methadone dose requirements, and provides an example of the utility of controlling for known genotype/allelic associations in determining additional variants contributing to genetics associations.
4. Bart G, Heilig M, LaForge KS, Pollak L, Leal SM, Ott J, et al. Substantial attributable risk related to a functional mu-opioid receptor gene polymorphism in association with heroin addiction in central sweden. Mol Psychiatry. 2004;9(6):547–9. doi: 10.1038/sj.mp.4001504 .
5. Kroslak T, Laforge KS, Gianotti RJ, Ho A, Nielsen DA, Kreek MJ. The single nucleotide polymorphism a118g alters functional properties of the human mu opioid receptor. J Neurochem. 2007;103(1):77–87. doi: 10.1111/j.1471-4159.2007.04738.x .
Cited by
42 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献